Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: a systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology

Related articles

1. A multicenter, phase II trial of triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for highly emetogenic chemotherapy in breast cancer (PATROL-II)

   This article has 15 authors:

   1. Kenichi Suzuki
   2. Takashi Yokokawa
   3. Takashi Kawaguchi
   4. Shinya Takada
   5. Shinya Tamaki
   6. Yohei Kawasaki
   7. Takumi Yamaguchi
   8. Kei Koizumi
   9. Takuma Matsumoto
   10. Yukio Sakata
   11. Yuichiro Arakawa
   12. Hideaki Ayuhara
   13. Mari Hosonaga
   14. Masakazu Yamaguchi
   15. Daiki Tsuji

2. Palliative patients who may benefit from intranasal delivery of symptomatic drugs: a two-center observational study evaluated the administration of morphine and dexamethasone in Polish hospices

   This article has 4 authors:

   1. Anna Ingielewicz
   2. Zuzanna Brunka
   3. Mateusz Szczupak
   4. Robert Szymczak

3. Short-term and long-term oncological outcomes of chemoradiotherapy for rectal cancer patients with or without oxaliplatin: a propensity score-matched retrospective analysis

   This article has 22 authors:

   1. Amirali Azimi
   2. Fatemeh Sadat Tabatabaei
   3. Kasra Kolahdouzan
   4. Hamideh Rashidian
   5. Forouzan Nourbakhsh
   6. Maryam Abedini Parizi
   7. Nima Mousavi Darzikolaee
   8. Reyhaneh Bayani
   9. Samaneh Salarvand
   10. Azadeh Sharifian
   11. Farzaneh Bagheri
   12. Saeed Rezaei
   13. Naeim Nabian
   14. Reza Nazari
   15. Negin Mohammadi
   16. Mohammad Babaei
   17. Marzieh Lashkari
   18. Farshid Farhan
   19. Mahdi Aghili
   20. Felipe Couñago
   21. Maria Antonietta Gambacorta
   22. Reza Ghalehtaki